Replies to post #746 on Trius Therapeutics, Inc. (TSRX)

[noretreat]

At 13.50 now plus a fairly certain 2 bucks in 2017, your stock is worth 14-14.25 right now. Institutions control significant TSRX stock. If they think the deal is undervalued they will put up a fight even though the TSRX board has approved it (I think they have, anyway). At that point the company would be difficult to value, but it would still be at least 14 bucks. The only stickler would be if the whole deal went south because of lawsuits, and other potential buyers did not come forward. That could end up anywhere, and the market would price the stock conservatively, possibly under 13.50.